Long-Term Benefit With First-Line Osimertinib Monotherapy in EGFR-Mutated Advanced NSCLC in the Era of Intensified First-Line Therapy

Journal of Thoracic Oncology · Elsevier

Аннотация

Publication date: Available online 21 September 2026 Source: Journal of Thoracic Oncology Author(s): Masaki Ishida, Tadaaki Yamada, Ou Yamaguchi, Yasuhiro Goto, Tomohiro Oba, Kazuki Shimamoto, Takeshi Tsuda, Ichidai Tanaka, Shizuka Shiraishi, Naoki Furuya, Akihiro Yoshimura, Keisuke Mine, Tomoaki Ota, Makoto Hibino, Yoshihito Kogure, Toshiyuki Iwata, Satoshi Watanabe, Hisashi Tanaka, Tamio Okimoto, Izumi Sato

Читать у издателя →

Похожие статьи